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Method details {#se0155}
==============

Current study was done in the stages as follows: sampling and preparation of PM~10~ suspension and hemolysis test including preparation of standards and controls, preparation of blood, blood sample treatment, and measurement of hemoglobin concentration and calculation of hemolysis percent. Finally, statistical analysis was carried out on data. Flow diagram of the study stages are exhibited in [Fig. 1](#fig0005){ref-type="fig"}.Fig. 1Flow diagram of the study stages.Fig. 1

Sampling and preparation of PM~10~ suspension {#sec0005}
=============================================

Sampling of particle was described in detail in our previous works \[[@bib0005]\]. Briefly, PM~10~ was sampled by a high-volume sampler (1.3--1.7 m^3^/min) (Grasebey, USA) on the fiberglass filter (8 × 10 in., grade G 653 Whatman, USA). Sampled particles was extracted as the dry ultrasonic method that described in detail before \[[@bib0010]\]. PM~10~ suspension was prepared in phosphate buffered saline (PBS) (Biosera, France) at six concentrations of 50, 100, 150, 200, 250 and 300 μg/mL.

Hemolysis test {#sec0010}
==============

Hemolysis test were surveyed in the basis of ASTM standard E2524-08 (Standard Test Method for Analysis of Hemolytic Properties of Nanoparticles) with some modifications in the concentration of analyzed particles \[[@bib0015],[@bib0020]\]. The ethics committee of the Tehran University of Medical Sciences approved current study (IR.TUMS.SPH.REC.1395.841). Written informed consent was obtained from volunteers and their parents before initiating the study.

Preparation of standards and controls {#sec0015}
-------------------------------------

### Standards {#sec0020}

Hemoglobin standards were prepared by means of hemoglobin standard (StanBio Laboratory, Boerne, TX, USA) and cyanmethemoglobin (CMH) reagent (Sigma-Aldrich, St. Louis, MO, USA) that used to construct a standard curve at the range of hemoglobin concentration from 0 to 200 mg/mL ([Table 1](#tbl0005){ref-type="table"}).Table 1Preparation of Calibration Standards.Table 1StandardNominal Concentration (mg/mL)Preparation ProcedureStandard (μL)CMH reagent (μL)S100200S28080120S312012080S416016040S518018020S62002000

### Positive control {#sec0025}

Triton X-100 (Sigma-Aldrich, St. Louis, MO, USA) at a stock concentration of 1% (10 mg/mL) was used as the assay positive control. Triton X-100 can be prepared in the sterile distilled water and kept at 4 °C for up to 2 weeks.

### Negative control {#sec0030}

Sterile solution of PBS was used as the negative control that could store the stock solution at room temperature.

### Blood-free control {#sec0035}

Particles that could not be removed after centrifugation of samples may cause false positive results. These false positive results were corrected by aliquots of PM~10~ suspension at corresponding concentrations those used in the assay in PBS without blood.

### Inhibition/enhancement control (IEC) {#sec0040}

This control is used to approximate potential interaction between air particles and hemoglobin released in the supernatant, which may mask hemoglobin from detection, by the assay. False negative results were corrected by spiking cell-free supernatant, from the positive control after centrifugation, to particles at corresponding concentrations those used in the assay \[[@bib0015],[@bib0020]\].

Preparation of blood {#sec0045}
--------------------

Whole blood from three donors 16--18 years old was collected into a syringe containing heparin as an anti-coagulant. The inclusion criteria for volunteers were: being healthy at the time of taking blood, nonsmoking (no smoking at least 6 months before the study), no taking regular medication, no experiencing any inflammation during blood sampling and one week ago, and no occupational exposure to environmental pollutants. Equal proportions of collected whole blood were pooled and diluted ten times with PBS. Diluted blood was used in all of the samples with blood.

Blood sample treatment {#sec0050}
----------------------

Aliquots (100 μl) of PM~10~ suspension in PBS at the mentioned mass concentrations were added to microcentrifuge tubes. Then, 700 μl of PBS and 100 μl of diluted blood were added to the sample, positive and negative control tubes. All of samples were prepared in triplicate. These were incubated at a 37 °C water bath for 3 h, following gentle inversion of the tubes every 30 min. After the incubation, particles and intact RBCs were removed through centrifugation of tubes at 800 *g* for 15 min at room temperature.

Measurement of hemoglobin concentration {#sec0055}
---------------------------------------

Hemoglobin concentration was measured by the cyanmethemoglobin method \[[@bib0015],[@bib0020]\]. Total blood hemoglobin (TBH) was prepared by combining 20 μL of diluted blood with 5 mL of CMH reagent.

200 μL of blank (CMH reagent), total blood hemoglobin (TBH) sample that its preparation described above and standards ([Table 1](#tbl0005){ref-type="table"}) was added in each well on a 96 well plate (See Plate map in [Fig. 2](#fig0010){ref-type="fig"}). Also, 100 μL of supernatant of test samples and controls (positive, negative, blood-free and IEC) was added on the plate and mixed in a 1:1 ratio with cyanmethemoglobin (CMH) reagent. Absorbance of each sample was read at an absorbance wavelength of 540 nm. Hemoglobin concentration was calculated according to the standard curve constructed through hemoglobin standards. Dilution factor 18 was accounted for samples and controls, and 251 for TBH.Fig. 2Plate map; S = Standard, PMn = Particle matter at concentrations of 1--6 corresponding to 50--300 μg/mL, NB = No blood, PC = Positive control, NC = Negative control, IECn = Inhibition/enhancement control at concentrations of 1--6 corresponding to 50--300 μg/mL, TBH = Total blood hemoglobin.Fig. 2

Calculation of hemolysis percent {#sec0060}
--------------------------------

Hemolysis percent was calculated from Eq. [(1)](#eq0005){ref-type="disp-formula"} by dividing each sample's hemoglobin concentration by the TBH.$$\text{Hemolysis}\,\quad\left( \% \right) = \text{Hemoglobine}\,\quad\text{in}\,\text{test}\,\text{sample/TBH} \times 100$$Hemolysis percent in samples is interpreted as follow: \<2%: non-hemolytic, 2--5%: slightly hemolytic and \>5% hemolytic samples \[[@bib0015]\].

Statistical analysis {#sec0065}
====================

The effect of PM~10~ concentration at six levels (50, 100, 150, 200, 250 and 300 μg/ml) on the hemolysis percent as the response was investigated with R software version 3.4.3 \[[@bib0025],[@bib0030]\]. Significant level was considered as p-value less than 0.05. Analysis of variance (ANOVA) followed by Tukey post-hoc test was applied to compare the hemolysis percent between different PM concentrations.
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